Equity Profile

SYK

Stryker Corporation

Health CareHealth Care Equipment$117.2B

Apr30Thu

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

Stryker Corporation Misses on EPS, Stock Up 0.00%

Metric	Actual	Expected	Surprise
EPS	$2.60	$2.98	-12.63%
Revenue	N/A	$6.3B	N/A

management commentary, guidance changes, and full analysis available with Pro.

Stryker Corporation Misses on EPS, Stock Up 0.00%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$2.60	$2.98	-12.63%
Revenue	N/A	$6.3B	N/A

Management Commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.

What It Means

Stryker Corporation reported earnings that fell short of analyst expectations, particularly in EPS. Despite the miss, the stock showed no movement, remaining stable. Investors may be awaiting further insights from future earnings calls or additional guidance.

Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment. Operating in the health care sector, Stryker focuses on products that enhance surgical outcomes and improve patient care, making it a significant player in the medical device industry.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Stryker is managing costs and generating income.

$2.98

Revenue

Total revenue reflects the company's sales performance and market demand for its products, which is crucial for assessing growth.

$6.3B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q4-2025, Stryker reported an EPS of $4.47, beating estimates by 1.71%. However, the stock experienced a slight decline of 0.99% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Stryker to continue its trend of exceeding earnings expectations, with a consensus EPS of $2.98 and revenue of $6.3B. The market is closely watching for any signs of growth in demand for its products.

Bull Case

If Stryker beats earnings expectations again, it could indicate strong operational efficiency and demand, potentially driving the stock higher as investors gain confidence in its growth trajectory.

Bear Case

Conversely, if Stryker fails to meet expectations, it may raise concerns about market demand and profitability, leading to a negative reaction from investors.

Key Metrics to Watch

EPS

$2.98

Earnings per share is a key indicator of profitability and will show how well Stryker is managing costs and generating income.

Revenue

$6.3B

Total revenue reflects the company's sales performance and market demand for its products, which is crucial for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Stryker's EPS exceed the consensus estimate of $2.98?

A beat on EPS would reinforce Stryker's strong operational performance and could boost investor confidence.

What are the revenue growth prospects for Stryker's key product lines?

Understanding revenue growth will provide insight into market demand and the company's competitive position in the healthcare equipment sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Stryker's ability to leverage its innovative product pipeline, which could lead to stronger-than-expected revenue growth this quarter.

Supporting Evidence

Stryker has consistently beaten EPS estimates in the past, indicating strong operational execution.

The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news.

Recent insider trading activity shows mixed signals, which may indicate uncertainty about future performance.

Key Risk

If Stryker's revenue growth exceeds $6.5B, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on Stryker's ability to maintain its growth trajectory amid competitive pressures and market dynamics.

Bull Confirmed If

An EPS of $3.05 or higher would confirm the bull case, indicating strong demand and cost management.

Bear Confirmed If

An EPS below $2.86 would confirm the bear case, suggesting potential issues with profitability or market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±6.51%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a significant move around the earnings report, suggesting that traders expect volatility based on the upcoming results.

Options are pricing ±6.5% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

19.6%

Calls (72K)P/C Ratio: 1.01Puts (41K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could rise by about 0.84%, confirming strong operational performance.

In-Line / Cautious

An inline result may lead to a muted reaction, as investors await further guidance on future growth.

Miss

If Stryker misses expectations, the stock could decline, with historical patterns suggesting a potential drop of around 0.63%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-NJThomas H. Kean JrRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand and competitive landscape.
3Insights into cost management strategies and their effect on margins.
4Guidance on future revenue growth and any changes to long-term targets.
5Responses to questions regarding supply chain challenges and their impact on operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr27

CINFReported

Cincinnati Financial Corporation

RecapView

Apr27

CCKReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Stryker is managing costs and generating income.

$2.98

Revenue

Total revenue reflects the company's sales performance and market demand for its products, which is crucial for assessing growth.

$6.3B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q4-2025, Stryker reported an EPS of $4.47, beating estimates by 1.71%. However, the stock experienced a slight decline of 0.99% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Stryker beats earnings expectations again, it could indicate strong operational efficiency and demand, potentially driving the stock higher as investors gain confidence in its growth trajectory.

Bear Case

Conversely, if Stryker fails to meet expectations, it may raise concerns about market demand and profitability, leading to a negative reaction from investors.

Key Metrics to Watch

EPS

$2.98

Earnings per share is a key indicator of profitability and will show how well Stryker is managing costs and generating income.

Revenue

$6.3B

Total revenue reflects the company's sales performance and market demand for its products, which is crucial for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Stryker's EPS exceed the consensus estimate of $2.98?

A beat on EPS would reinforce Stryker's strong operational performance and could boost investor confidence.

What are the revenue growth prospects for Stryker's key product lines?

Understanding revenue growth will provide insight into market demand and the company's competitive position in the healthcare equipment sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Stryker's ability to leverage its innovative product pipeline, which could lead to stronger-than-expected revenue growth this quarter.

Supporting Evidence

Stryker has consistently beaten EPS estimates in the past, indicating strong operational execution.

The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news.

Recent insider trading activity shows mixed signals, which may indicate uncertainty about future performance.

Key Risk

If Stryker's revenue growth exceeds $6.5B, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on Stryker's ability to maintain its growth trajectory amid competitive pressures and market dynamics.

Bull Confirmed If

An EPS of $3.05 or higher would confirm the bull case, indicating strong demand and cost management.

Bear Confirmed If

An EPS below $2.86 would confirm the bear case, suggesting potential issues with profitability or market demand.

Pre-Earnings Positioning

Options Market

Implied Move

±6.51%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a significant move around the earnings report, suggesting that traders expect volatility based on the upcoming results.

Options are pricing ±6.5% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

19.6%

Calls (72K)P/C Ratio: 1.01Puts (41K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could rise by about 0.84%, confirming strong operational performance.

In-Line / Cautious

An inline result may lead to a muted reaction, as investors await further guidance on future growth.

Miss

If Stryker misses expectations, the stock could decline, with historical patterns suggesting a potential drop of around 0.63%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$15,001.00–$50,000.00

disclosed dollar ranges

Most Active Members

R-NJThomas H. Kean JrRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand and competitive landscape.
3Insights into cost management strategies and their effect on margins.
4Guidance on future revenue growth and any changes to long-term targets.
5Responses to questions regarding supply chain challenges and their impact on operations.